Americans Are Living Longer Again

After years of pandemic-driven declines that wiped out decades of progress, American life expectancy is firmly back on an upward trajectory. Data released today by the Centers for Disease Control and Prevention shows that life expectancy at birth reached 79.1 years in 2025, up from 78.4 in 2024 and surpassing the pre-pandemic high of 78.9 years set in 2014.

The 0.7-year increase is the largest single-year gain since the 1940s, reflecting the convergence of several positive health trends including declining drug overdose deaths, reduced COVID-19 mortality, and improvements in cardiovascular disease outcomes.

Breaking Down the Numbers

The gains were not equally distributed across demographic groups, though every major population segment showed improvement:

The persistent 5.3-year gap between men and women remains one of the most consistent findings in U.S. health data, driven largely by higher rates of heart disease, suicide, and accidental death among men.

What's Driving the Improvement

CDC analysts identified three primary factors behind the rebound:

1. Drug overdose deaths declined for the first time in a decade. Provisional data indicates approximately 85,000 overdose fatalities in 2025, down from the peak of 112,000 in 2023. Public health officials credit expanded access to naloxone, the opioid reversal agent, along with fentanyl test strips and medication-assisted treatment programs. Several states that legalized supervised consumption sites also reported sharper-than-average declines.

2. COVID-19 mortality continued to fall. With widespread hybrid immunity from both vaccination and prior infection, COVID-19 dropped to the ninth leading cause of death in 2025, down from third in 2021 and first in 2020. Updated vaccines targeting current variants and expanded access to antiviral treatments like Paxlovid contributed to the decline.

3. Cardiovascular disease outcomes improved. Heart disease remains the leading cause of death, but mortality rates fell 4.2 percent in 2025. Researchers attribute this partly to the rapid adoption of GLP-1 receptor agonist medications, which reduce cardiovascular risk beyond their weight loss effects, and partly to better hypertension management through expanded telehealth services.

"This is genuinely good news, and it reflects the cumulative impact of targeted public health investments," said Dr. Mandy Cohen, CDC Director. "But we still lag behind most peer nations, and the disparities within our own population demand continued attention."

The International Context

Despite the gains, the United States continues to trail most wealthy nations in life expectancy. Japan leads at 84.7 years, followed by Switzerland at 83.9 and Australia at 83.5. The U.S. ranks 46th globally, a position that health policy experts attribute to higher rates of gun violence, obesity, lack of universal healthcare coverage, and socioeconomic inequality.

Challenges That Remain

Several threats could stall or reverse the progress. Maternal mortality remains alarmingly high by international standards, particularly for Black women. Suicide rates, while stabilizing, have not declined meaningfully. And the long-term health effects of the obesity epidemic — despite the growing availability of weight loss medications — continue to drive diabetes, cancer, and joint disease.

Mental health experts also note that while life expectancy measures quantity of life, it says nothing about quality. Rising rates of depression, anxiety, and loneliness, particularly among young adults, represent a parallel crisis that traditional life expectancy metrics do not capture.

Looking Ahead

Demographers project that if current trends continue, U.S. life expectancy could reach 80 years by 2028 — a milestone the country has never achieved. Whether the nation can sustain this trajectory will depend on continued investment in addiction treatment, chronic disease prevention, and the reduction of health disparities across racial, economic, and geographic lines.